KKR, Hildred and EQT Life Sciences Invest in Diagnostics Company Onvaro

PUBT · 1d ago
KKR, Hildred and EQT Life Sciences Invest in Diagnostics Company Onvaro
  • KKR-managed funds, Hildred and EQT Life Sciences are investing new capital in Onvaro to support its growth.
  • Formed through the combination of Sapphiros and binx health, Onvaro develops diagnostics for health care and consumer settings.
  • The investment will support commercial expansion and development of decentralized testing products.
  • Onvaro's commercial portfolio centers on the binx io molecular point-of-care platform, with more than 1,000 installed instruments.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KKR & Co. Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261104492716) on November 04, 2026, and is solely responsible for the information contained therein.